RT Journal Article
SR Electronic
T1 Theta autoregressive neural network model for COVID-19 outbreak predictions
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.01.20205021
DO 10.1101/2020.10.01.20205021
A1 Chakraborty, Tanujit
A1 Bhattacharyya, Arinjita
A1 Pattnaik, Monalisha
YR 2020
UL http://medrxiv.org/content/early/2020/10/02/2020.10.01.20205021.abstract
AB An unprecedented outbreak of the novel coronavirus (COVID-19) in the form of peculiar pneumonia has spread globally since its first case at Wuhan, China, in December 2019, increasing infected cases and mortality at a pandemic speed. Thus, forecasting the COVID-19 pandemic became a key research interest for both the epidemiologists and statisticians. These future predictions are useful for the effective allocation of health care resources, stockpiling, and help in strategic planning for clinicians, government authorities, and public-health policymakers after understanding the extent of the effect. The main objective of this paper is to develop the most suitable forecasting model that can generate real-time short-term (ten days) and long-term (fifty days) out-of-sample forecasts of COVID-19 outbreaks for eight profoundly affected countries, namely the United States of America, Brazil, India, Russia, South Africa, Mexico, Spain, and Iran. A novel hybrid approach based on the Theta model and Autoregressive neural network (ARNN) model, named Theta-ARNN (TARNN) model, is proposed. The proposed method outperforms previously available single and hybrid forecasting models for COVID-19 predictions in most data sets. In addition, the ergodicity and asymptotic stationarity of the proposed TARNN model are established which is of particular interest in nonlinear time series literature. An R-Shiny application is created for implementation of TARNN model and is publicly available1.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNot applicable.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No trials are done in this paper.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and codes are available at: https://github.com/arinjita9/COVID-19-Forecasting-by-TARNN-https://github.com/arinjita9/COVID-19-Forecasting-by-TARNN-ANNArtificial Neural NetworkARIMAAuto Regressive Integrated Moving AverageARNNAuto Regressive Neural NetworkCFRCase-Fatality RateIRIncidence RateJBJarque–Bera testSARS-Cov-2Severe Acute Respiratory Syndrome Coronavirus-2TARNNTheta-ARNNUSAUnited States of AmericaWBFWavelet Based Forecasting